These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2562645)
21. The enhancement of host defenses against infection--search for the Holy Grail? Polk HC Surgery; 1986 Jan; 99(1):1-6. PubMed ID: 3941994 [TBL] [Abstract][Full Text] [Related]
22. Activation of immune responses by muroctasin. Akasaki M Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427 [TBL] [Abstract][Full Text] [Related]
24. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production]. Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372 [TBL] [Abstract][Full Text] [Related]
25. Induction of interleukin 1 by synthetic and naturally occurring muramyl peptides. Dinarello CA; Krueger JM Fed Proc; 1986 Oct; 45(11):2545-8. PubMed ID: 3489643 [TBL] [Abstract][Full Text] [Related]
26. Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide. Bahr GM J Antimicrob Chemother; 2003 Jan; 51(1):5-8. PubMed ID: 12493780 [No Abstract] [Full Text] [Related]
27. Specific binding sites for muramyl peptides on murine macrophages. Silverman DH; Krueger JM; Karnovsky ML J Immunol; 1986 Mar; 136(6):2195-201. PubMed ID: 3950411 [TBL] [Abstract][Full Text] [Related]
28. Epitope specific immunity elicited by totally synthetic monovalent or polyvalent vaccines. Chedid L; Audibert F; Jolivet M; Carelli C; Uzan M; Gras-Masse H; Tarter A Ann Sclavo Collana Monogr; 1984; 1(2):77-85. PubMed ID: 6400358 [No Abstract] [Full Text] [Related]
29. Muramyl peptides in mammalian tissues and their effects at the cellular level. Karnovsky ML Fed Proc; 1986 Oct; 45(11):2556-60. PubMed ID: 3758374 [TBL] [Abstract][Full Text] [Related]
30. Induction of murine macrophage tumoricidal activity and treatment of experimental pulmonary metastases by liposomes containing lipophilic muramyl dipeptide analogs. Phillips NC; Chedid L; Bernard JM; Level M; Lefrancier P J Biol Response Mod; 1987 Dec; 6(6):678-91. PubMed ID: 3450784 [TBL] [Abstract][Full Text] [Related]
31. Potential adjuvants for synthetic vaccines. I. Modulators of macrophage activation. Solange A Chem Phys Lipids; 1995 Jan; 75(1):51-8. PubMed ID: 7697782 [TBL] [Abstract][Full Text] [Related]
32. Experimental and clinical studies on the effects of synthetic muramyldipeptide derivatives on viral and opportunistic infections. Yamamura Y; Ishihara C; Hamada N; Yamamoto K; Azuma I Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):11-4. PubMed ID: 3010013 [TBL] [Abstract][Full Text] [Related]
33. [Muramyl dipeptide (MDP): its origin, mechanism of action and prospects for its use]. Castrillón LE Salud Publica Mex; 1987; 29(6):492-9. PubMed ID: 3125614 [No Abstract] [Full Text] [Related]